Charlotte Heart Group Research Center
Port Charlotte, Florida, United States
Fertility physician in Port Charlotte, Florida
3340 Tamiami Trail, Port Charlotte, FL 33952
About Charlotte Heart Group Research Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boston Scientific Corporation
3
Otsuka Pharmaceutical Development & Commercialization, Inc.
2
Pfizer
2
Saint Luke's Health System
2
Amgen
1
Boehringer Ingelheim
1
Brigham and Women's Hospital
1
CardioKine Inc.
1
Cardiovascular Clinical Studies
1
Cogentus Pharmaceuticals
1
Duke University
1
Clinical Trials at Charlotte Heart Group Research Center
During the past decade, Charlotte Heart Group Research Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 9 clinical trials were completed, i.e. on
average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
2002-07-01
2004-07-01
Completed
170
EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan
2003-09-01
2006-07-01
Completed
3,600
Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg
2005-10-01
2006-07-01
Completed
400
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure
2010-01-01
Completed
170
Longitudinal Surveillance Study of the 4-SITE Lead/Header System
2013-04-04
2020-02-18
Completed
1,820
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
2013-11-01
2014-02-01
Terminated
23
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Charlotte Heart Group Research Center" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Saint Luke's Health System" with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Charlotte Heart Group Research Center"
#1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Boston VA Research Institute, Inc." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cardiokine Biopharma, LLC" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Charlotte Heart Group Research Center
According to Clinical.Site data, the most researched conditions in "Charlotte Heart Group Research Center" are
"Cardiovascular Disease" (3 trials), "Congestive Heart Failure" (3 trials), "Myocardial Infarction" (3 trials), "Coronary Artery Disease" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Charlotte Heart Group Research Center" in a lesser frequency.
Clinical Trials Intervention Types at Charlotte Heart Group Research Center
Most popular intervention types in "Charlotte Heart Group Research Center" are "Drug" (13 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Dapagliflozin matching placebo" (2 trials), "Tolvaptan" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Arm 1 (ATP+Shock)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Charlotte Heart Group Research Center
The vast majority of trials in "Charlotte Heart Group Research Center" are
18 trials for "All" genders.
Clinical Trials Status at Charlotte Heart Group Research Center
Currently, there are NaN active trials in "Charlotte Heart Group Research Center".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Charlotte Heart Group Research Center,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Charlotte Heart Group Research Center, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 1 trials that are defined as “Not Applicable".